Fig. 5.
Functional delivery of SSOs by the nanoconjugates. A. Comparison of dose-dependent eGFP induction by treatments with PMO and PAMAM-PMO10. B. Comparison of eGFP induction by the treatments of PAMAM-PMO10 and Lipoplexes of PS SSO.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.